Innovative Pharmaceutical Biotech Limited (SEHK:399) entered into a memorandum of understanding to acquire a majority interest in Niraxx Light Therapeutics, Inc. on September 4, 2023. The Consideration shall be settled by the Company in the form of convertible bonds to be issued by the Company upon Completion. Transaction is subject formal agreement and approval of offer by acquirer board